259 related articles for article (PubMed ID: 26617071)
1. State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 - Relation to antipsychotic-like drug effects.
Gould RW; Nedelcovych MT; Gong X; Tsai E; Bubser M; Bridges TM; Wood MR; Duggan ME; Brandon NJ; Dunlop J; Wood MW; Ivarsson M; Noetzel MJ; Daniels JS; Niswender CM; Lindsley CW; Conn PJ; Jones CK
Neuropharmacology; 2016 Mar; 102():244-53. PubMed ID: 26617071
[TBL] [Abstract][Full Text] [Related]
2. Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M
Gould RW; Grannan MD; Gunter BW; Ball J; Bubser M; Bridges TM; Wess J; Wood MW; Brandon NJ; Duggan ME; Niswender CM; Lindsley CW; Conn PJ; Jones CK
Neuropharmacology; 2018 Jan; 128():492-502. PubMed ID: 28729220
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.
Bubser M; Bridges TM; Dencker D; Gould RW; Grannan M; Noetzel MJ; Lamsal A; Niswender CM; Daniels JS; Poslusney MS; Melancon BJ; Tarr JC; Byers FW; Wess J; Duggan ME; Dunlop J; Wood MW; Brandon NJ; Wood MR; Lindsley CW; Conn PJ; Jones CK
ACS Chem Neurosci; 2014 Oct; 5(10):920-42. PubMed ID: 25137629
[TBL] [Abstract][Full Text] [Related]
4. M
Russell JK; Ingram SM; Teal LB; Lindsley CW; Jones CK
ACS Chem Neurosci; 2023 Feb; 14(3):435-457. PubMed ID: 36655909
[TBL] [Abstract][Full Text] [Related]
5. Modulation of arousal and sleep/wake architecture by M
Gould RW; Russell JK; Nedelcovych MT; Bubser M; Blobaum AL; Bridges TM; Newhouse PA; Lindsley CW; Conn PJ; Nader MA; Jones CK
Neuropsychopharmacology; 2020 Dec; 45(13):2219-2228. PubMed ID: 32868847
[TBL] [Abstract][Full Text] [Related]
6. Challenges in the development of an M
Wood MR; Noetzel MJ; Poslusney MS; Melancon BJ; Tarr JC; Lamsal A; Chang S; Luscombe VB; Weiner RL; Cho HP; Bubser M; Jones CK; Niswender CM; Wood MW; Engers DW; Brandon NJ; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
Bioorg Med Chem Lett; 2017 Jan; 27(2):171-175. PubMed ID: 27939174
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.
Byun NE; Grannan M; Bubser M; Barry RL; Thompson A; Rosanelli J; Gowrishankar R; Kelm ND; Damon S; Bridges TM; Melancon BJ; Tarr JC; Brogan JT; Avison MJ; Deutch AY; Wess J; Wood MR; Lindsley CW; Gore JC; Conn PJ; Jones CK
Neuropsychopharmacology; 2014 Jun; 39(7):1578-93. PubMed ID: 24442096
[TBL] [Abstract][Full Text] [Related]
8. The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia.
Barak S; Weiner I
Int J Neuropsychopharmacol; 2011 Oct; 14(9):1233-46. PubMed ID: 21211109
[TBL] [Abstract][Full Text] [Related]
9. New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug).
Nawaratne V; Leach K; Suratman N; Loiacono RE; Felder CC; Armbruster BN; Roth BL; Sexton PM; Christopoulos A
Mol Pharmacol; 2008 Oct; 74(4):1119-31. PubMed ID: 18628403
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M
Mandai T; Kasahara M; Kurimoto E; Tanaka M; Suzuki M; Nakatani A; Kimura H
Neuroscience; 2019 Aug; 414():60-76. PubMed ID: 31299348
[TBL] [Abstract][Full Text] [Related]
11. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release.
Foster DJ; Wilson JM; Remke DH; Mahmood MS; Uddin MJ; Wess J; Patel S; Marnett LJ; Niswender CM; Jones CK; Xiang Z; Lindsley CW; Rook JM; Conn PJ
Neuron; 2016 Sep; 91(6):1244-1252. PubMed ID: 27618677
[TBL] [Abstract][Full Text] [Related]
13. Activation of M
Cadeddu R; Braccagni G; Branca C; van Luik ER; Pittenger C; Thomsen MS; Bortolato M
Br J Pharmacol; 2024 Apr; ():. PubMed ID: 38689378
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Development of Muscarinic Acetylcholine M
Takai K; Enomoto T
Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M
Grannan MD; Mielnik CA; Moran SP; Gould RW; Ball J; Lu Z; Bubser M; Ramsey AJ; Abe M; Cho HP; Nance KD; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW; Jones CK
ACS Chem Neurosci; 2016 Dec; 7(12):1706-1716. PubMed ID: 27617634
[TBL] [Abstract][Full Text] [Related]
16. Clozapine alters sleep-wake behavior in rats.
Sorge S; Pollmächer T; Lancel M
Neuropsychopharmacology; 2004 Aug; 29(8):1462-9. PubMed ID: 15085087
[TBL] [Abstract][Full Text] [Related]
17. Optimized Administration of the M
Cikowski J; Holt C; Arthur B; Smith M; Gonzalez S; Lindsley CW; Niswender CM; Gogliotti RG
ACS Chem Neurosci; 2022 Jul; 13(13):1891-1901. PubMed ID: 35671352
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide-S evoked arousal with electroencephalogram slow-wave compensatory drive in rats.
Ahnaou A; Drinkenburg WH
Neuropsychobiology; 2012 Jun; 65(4):195-205. PubMed ID: 22538299
[TBL] [Abstract][Full Text] [Related]
19. Optimization of M
Melancon BJ; Wood MR; Noetzel MJ; Nance KD; Engelberg EM; Han C; Lamsal A; Chang S; Cho HP; Byers FW; Bubser M; Jones CK; Niswender CM; Wood MW; Engers DW; Wu D; Brandon NJ; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
Bioorg Med Chem Lett; 2017 Jun; 27(11):2296-2301. PubMed ID: 28442253
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]